WithdrawnNCT00571779
AtriCure Minimally Invasive Surgical Ablation for Atrial Fibrillation/RESTORE IIB
Device studyAges 18–80Bipolarity
Understand this study
Who could participate?
Listed age limits: 18 years to 80 years.
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- AtriCure, Inc.
- Sponsor type
- Other organization
- Study type
- Device
- Intervention type
- DEVICE
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Not clearly listed
- Age range
- From 18 Years to 80 Years
- Official registry ID
- NCT00571779
- Official title
Show the full official title
Thoracoscopically-Assisted Epicardial Bilateral Pulmonary Vein Isolations Using the AtriCure Bipolar System and Exclusion of the Left Atrial Appendage for the Treatment of Atrial Fibrillation
Recruitment & locations
WithdrawnThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Locations not listed
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is AtriCure, Inc.
Who can participate?
Listed age limits: 18 years to 80 years.
Is this study still recruiting?
The registry lists this study as withdrawn.
